ResearcherLankenau Institute for Medical ResearchNo recent work listed
George C Prendergast
Matched on ORCID iD 0000-0002-1449-7332; OpenAlex author ID A5089381889; NIH RePORTER profile ID 1863878. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 3
- Labs led
- 1
- Collaborators
- 17
2012: 1 grant · 2013: 1 grant · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 grant · 2020: none · 2021: 1 paper
Papers 2
- The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Co-author DOI 10.1158/1535-7163.mct-20-0652↗
- A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2. Co-author DOI 10.1016/j.jamcollsurg.2017.12.052↗
Grants 3
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan Robert Brody · 2 shared papers, 2018–2021 · strength 0.17
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Paper A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,… DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Charles J. Yeo · 2 shared papers, 2018–2021 · strength 0.17
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Paper A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,… DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Avinoam Nevler · 2 shared papers, 2018–2021 · strength 0.17
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Paper A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,… DOI 10.1016/j.jamcollsurg.2017.12.052↗
- Iraimoudi S Ayene · 1 shared grant, 2013 · strength 0.15
- Aditi Jain · 1 shared paper, 2021 · strength 0.09
- Christopher William Schultz · 1 shared paper, 2021 · strength 0.09
- Talia Golan · 1 shared paper, 2021 · strength 0.09
- Matthew McCoy · 1 shared paper, 2021 · strength 0.09
- Emanuel F. Petricoin · 1 shared paper, 2021 · strength 0.09
- Samantha Z. Brown · 1 shared paper, 2021 · strength 0.09
- Grace A. McCarthy · 1 shared paper, 2021 · strength 0.09
- Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.09
- Michael Jon Pishvaian · 1 shared paper, 2021 · strength 0.09
- Dan A. Dixon · 1 shared paper, 2021 · strength 0.09
- Theresa Pluth Yeo · 1 shared paper, 2018 · strength 0.08
- Harish Lavu · 1 shared paper, 2018 · strength 0.08
- Jordan Michael Winter · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.